Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Chris, Cano"'
Autor:
Yu-Sheng Yu, Khaled AboulFotouh, Gerallt Williams, Julie Suman, Chris Cano, Zachary N. Warnken, Robert O. Williams, Zhengrong Cui
Intranasal vaccination by directly applying a vaccine dry powder is appealing. However, a method that can be used to transform a vaccine from a liquid to a dry powder and a device that can be used to administer the powder to the desired region(s) of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e3512bd8436d209a275eb622b401f95
https://doi.org/10.1101/2022.11.01.514748
https://doi.org/10.1101/2022.11.01.514748
Autor:
Yu-Sheng Yu, Khaled AboulFotouh, Haiyue Xu, Gerallt Williams, Julie Suman, Chris Cano, Zachary N. Warnken, Kevin C.-W. Wu, Robert O. Williams, Zhengrong Cui
Publikováno v:
International Journal of Pharmaceutics. 640:122990
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a47098dfa3e86156802cb4d1e775e7c
https://doi.org/10.1016/j.ijpharm.2023.122990
https://doi.org/10.1016/j.ijpharm.2023.122990
Autor:
Khaled, AboulFotouh, Naoko, Uno, Haiyue, Xu, Chaeho, Moon, Sawittree, Sahakijpijarn, Dale J, Christensen, Gregory J, Davenport, Chris, Cano, Ted M, Ross, Robert O, Williams Iii, Zhengrong, Cui
Publikováno v:
International Journal of Pharmaceutics. 624:122021
MF59® is an oil-in-water (O/W) nanoemulsion-based vaccine adjuvant that is often used in seasonal and pandemic influenza vaccines. We explored the feasibility of developing dry powders of vaccines adjuvanted with MF59 or AddaVax™, a preclinical gr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9ef14752c3d5453f07e05fad447cab7
https://doi.org/10.1016/j.ijpharm.2022.122021
https://doi.org/10.1016/j.ijpharm.2022.122021